Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.

Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check12 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1; the clinical trial record history is otherwise unchanged.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe study record history now shows a new revision label 'Revision: v3.7.0' and updates the contact information link text capitalization, with the prior 'Find Contact Information' entry and 'Revision: v3.6.6' removed.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision label, v3.6.6, was added to the page history, replacing the previous v3.6.5. This indicates a minor update to the record's revision metadata without changing the study details.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision entry, Revision: v3.6.5, was added to the record history, indicating an update to the page’s versioning. No study data or visible content changes are indicated by this update.SummaryDifference0.1%

- Check89 days agoChange DetectedA new page revision, v3.6.4, was added to the record history and the previous revision v3.6.3 was removed, reflecting an internal update to the page's version history.SummaryDifference0.1%

Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.